Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2021

Open Access 01-06-2021 | Obesity | Original Article

Gender-Specific Risk Factors for Reflux Esophagitis in a Predominantly Hispanic Population of a Large Safety-Net Hospital

Authors: Shida Haghighat, Caron Park, Brian Horwich, Yao Liu, Edy Soffer, Gregory Idos, Anisa Shaker

Published in: Digestive Diseases and Sciences | Issue 6/2021

Login to get access

Abstract

Background

Defining factors associated with severe reflux esophagitis allows for identification of subgroups most at risk for complications of strictures and esophageal malignancy. We hypothesized there might be unique clinical features in patients with reflux esophagitis in a predominantly Hispanic population of a large, safety-net hospital.

Aim

Define clinical and endoscopic features of reflux esophagitis in a predominantly Hispanic population of a large, safety-net hospital.

Methods

This is retrospective comparative study of outpatients and hospitalized patients identified with mild (Los Angeles Grade A/B) and severe (Los Angeles Grade C/D) esophagitis through an endoscopy database review. The electronic medical record was reviewed for demographic and clinical data.

Results

Reflux esophagitis was identified in 382/5925 individuals: 56.5% males and 79.8% Hispanic. Multivariable logistic regression model adjusted for age, gender, race, body mass index (BMI), tobacco and alcohol use, and hospitalization status with severity as the outcome showed an interaction between gender and BMI (p ≤ 0.01). Stratification by gender showed that obese females had decreased odds of severe esophagitis compared to normal BMI females (OR = 0.18, 95% CI = 0.07-0.47; p < 0.01). In males, the odds of esophagitis were higher in inpatient status (OR = 2.84, 95% CI = 1.52 − 5.28; p < 0.01) and as age increased (OR = 1.37, 95% CI = 1.03 − 1.83; p = 0.03).

Conclusions

We identify gender-specific associations with severe esophagitis in a predominantly Hispanic cohort. In females, obese BMI appears to be protective against severe esophagitis compared to normal BMI, while in men inpatient status and increasing age were associated with increased odds of severe esophagitis.
Literature
1.
go back to reference El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the Epidemiology of Gastro-Oesophageal Reflux Disease: a Systematic Review. Gut. 2014;63:871–880.CrossRef El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the Epidemiology of Gastro-Oesophageal Reflux Disease: a Systematic Review. Gut. 2014;63:871–880.CrossRef
2.
go back to reference Parasa S, Sharma P. Complications of Gastro-Oesophageal Reflux Disease. Best Pract Res Clin Gastroenterol. 2013;27:433–442.CrossRef Parasa S, Sharma P. Complications of Gastro-Oesophageal Reflux Disease. Best Pract Res Clin Gastroenterol. 2013;27:433–442.CrossRef
3.
go back to reference El-Serag HB, Johanson JF. Risk Factors for the Severity of Erosive Esophagitis in Helicobacter Pylori-Negative Patients with Gastroesophageal Reflux Disease. Scandinavian J Gastroenterol. 2002;37:899–904.CrossRef El-Serag HB, Johanson JF. Risk Factors for the Severity of Erosive Esophagitis in Helicobacter Pylori-Negative Patients with Gastroesophageal Reflux Disease. Scandinavian J Gastroenterol. 2002;37:899–904.CrossRef
4.
go back to reference Katzka DA, Pandolfino JE, Kahrilas PJ. Phenotypes of Gastroesophageal Reflux Disease: Where Rome, Lyon, and Montreal Meet. Clin Gastroenterol Hepatol. 2020;18(4):767–776.CrossRef Katzka DA, Pandolfino JE, Kahrilas PJ. Phenotypes of Gastroesophageal Reflux Disease: Where Rome, Lyon, and Montreal Meet. Clin Gastroenterol Hepatol. 2020;18(4):767–776.CrossRef
5.
go back to reference Spechler SJ, Jain SK, Tendler DA, Parker RA. Racial Differences in the Frequency of Symptoms and Complications of Gastro-Oesophageal Reflux Disease. Aliment Pharmacol Therapeut.. 2002;16:1795–1800.CrossRef Spechler SJ, Jain SK, Tendler DA, Parker RA. Racial Differences in the Frequency of Symptoms and Complications of Gastro-Oesophageal Reflux Disease. Aliment Pharmacol Therapeut.. 2002;16:1795–1800.CrossRef
6.
go back to reference El-Serag HB, Graham DY, Satia JA, Rabeneck L. Obesity is an Independent Risk Factor for GERD Symptoms and Erosive Esophagitis. Am J Gastroenterol. 2005;100:1243–1250.CrossRef El-Serag HB, Graham DY, Satia JA, Rabeneck L. Obesity is an Independent Risk Factor for GERD Symptoms and Erosive Esophagitis. Am J Gastroenterol. 2005;100:1243–1250.CrossRef
7.
go back to reference Tack J, Pandolfino JE. Pathophysiology of Gastroesophageal Reflux Disease. Gastroenterology. 2018;154:277–288.CrossRef Tack J, Pandolfino JE. Pathophysiology of Gastroesophageal Reflux Disease. Gastroenterology. 2018;154:277–288.CrossRef
8.
go back to reference Abraham A, Lipka S, Hajar R, et al. Erosive Esophagitis in the Obese: the Effect of Ethnicity and Gender on its Association. Gastroenterol Res Pract. 2016;2016:7897390.CrossRef Abraham A, Lipka S, Hajar R, et al. Erosive Esophagitis in the Obese: the Effect of Ethnicity and Gender on its Association. Gastroenterol Res Pract. 2016;2016:7897390.CrossRef
9.
go back to reference Cai N, Ji GZ, Fan ZN, et al. Association Between Body Mass Index and Erosive Esophagitis: a Meta-Analysis. World J Gastroenterol WJG.. 2012;18:2545–2553.CrossRef Cai N, Ji GZ, Fan ZN, et al. Association Between Body Mass Index and Erosive Esophagitis: a Meta-Analysis. World J Gastroenterol WJG.. 2012;18:2545–2553.CrossRef
10.
go back to reference Nguyen AD, Spechler SJ, Shuler MN, Souza RF, Dunbar KB. Unique Clinical Features of Los Angeles Grade D Esophagitis Suggest that Factors Other Than Gastroesophageal Reflux Contribute to its Pathogenesis. J Clin Gastroenterol. 2019;53:9–14.CrossRef Nguyen AD, Spechler SJ, Shuler MN, Souza RF, Dunbar KB. Unique Clinical Features of Los Angeles Grade D Esophagitis Suggest that Factors Other Than Gastroesophageal Reflux Contribute to its Pathogenesis. J Clin Gastroenterol. 2019;53:9–14.CrossRef
11.
go back to reference Nilsson M, Lundegardh G, Carling L, Ye W, Lagergren J. Body Mass and Reflux Oesophagitis: an Oestrogen-Dependent Association? Scand J Gastroenterol. 2002;37:626–630.CrossRef Nilsson M, Lundegardh G, Carling L, Ye W, Lagergren J. Body Mass and Reflux Oesophagitis: an Oestrogen-Dependent Association? Scand J Gastroenterol. 2002;37:626–630.CrossRef
12.
go back to reference Asanuma K, Iijima K, Shimosegawa T. Gender Difference in Gastro-Esophageal Reflux Diseases. World J Gastroenterol WJG.. 2016;22:1800–1810.CrossRef Asanuma K, Iijima K, Shimosegawa T. Gender Difference in Gastro-Esophageal Reflux Diseases. World J Gastroenterol WJG.. 2016;22:1800–1810.CrossRef
13.
go back to reference Lee SW, Lien HC, Lee TY, Tung CF, Yeh HZ, Chang CS. Impact of Obesity on a Chinese Population with Erosive Esophagitis and Barrett’s Esophagus. Gut Liver.. 2017;11:377–382.CrossRef Lee SW, Lien HC, Lee TY, Tung CF, Yeh HZ, Chang CS. Impact of Obesity on a Chinese Population with Erosive Esophagitis and Barrett’s Esophagus. Gut Liver.. 2017;11:377–382.CrossRef
14.
go back to reference Younossi Z, Anstee QM, Marietti M, et al. Global Burden of NAFLD and NASH: Trends, Predictions, Risk Factors and Prevention. Nat Rev Gastroenterol Hepatol.. 2018;15:11–20.CrossRef Younossi Z, Anstee QM, Marietti M, et al. Global Burden of NAFLD and NASH: Trends, Predictions, Risk Factors and Prevention. Nat Rev Gastroenterol Hepatol.. 2018;15:11–20.CrossRef
15.
go back to reference Lagergren J. Influence of Obesity on the Risk of Esophageal Disorders. Nat Rev Gastroenterol Hepatol.. 2011;8:340–347.CrossRef Lagergren J. Influence of Obesity on the Risk of Esophageal Disorders. Nat Rev Gastroenterol Hepatol.. 2011;8:340–347.CrossRef
16.
go back to reference Nam SY, Choi IJ, Ryu KH, Park BJ, Kim HB, Nam BH. Abdominal Visceral Adipose Tissue Volume is Associated with Increased Risk of Erosive Esophagitis in Men and Women. Gastroenterology. 2010;139:1902–1911.CrossRef Nam SY, Choi IJ, Ryu KH, Park BJ, Kim HB, Nam BH. Abdominal Visceral Adipose Tissue Volume is Associated with Increased Risk of Erosive Esophagitis in Men and Women. Gastroenterology. 2010;139:1902–1911.CrossRef
17.
go back to reference Francois F, Roper J, Goodman AJ, et al. The Association of Gastric Leptin with Oesophageal Inflammation and Metaplasia. Gut. 2008;57:16–24.CrossRef Francois F, Roper J, Goodman AJ, et al. The Association of Gastric Leptin with Oesophageal Inflammation and Metaplasia. Gut. 2008;57:16–24.CrossRef
18.
19.
go back to reference Singh S, Sharma AN, Murad MH, et al. Central Adiposity is Associated with Increased Risk of Esophageal Inflammation, Metaplasia, and Adenocarcinoma: a Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Ass.. 2013;11:1399–1412. Singh S, Sharma AN, Murad MH, et al. Central Adiposity is Associated with Increased Risk of Esophageal Inflammation, Metaplasia, and Adenocarcinoma: a Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Ass.. 2013;11:1399–1412.
Metadata
Title
Gender-Specific Risk Factors for Reflux Esophagitis in a Predominantly Hispanic Population of a Large Safety-Net Hospital
Authors
Shida Haghighat
Caron Park
Brian Horwich
Yao Liu
Edy Soffer
Gregory Idos
Anisa Shaker
Publication date
01-06-2021
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2021
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06482-1

Other articles of this Issue 6/2021

Digestive Diseases and Sciences 6/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.